PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome
ObjectivesAutoantibodies are used clinically to phenotype and subset patients with autoimmune rheumatic diseases. We detected a novel 60 kDa autoantibody specificity by immunoblotting using a dermatomyositis (DM) patient's serum. Our objective was to identify the targeted autoantigen and to eva...
Saved in:
| Published in | Annals of the rheumatic diseases Vol. 75; no. 6; pp. 1145 - 1151 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Elsevier Limited
01.06.2016
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0003-4967 1468-2060 1468-2060 |
| DOI | 10.1136/annrheumdis-2015-207509 |
Cover
Loading…
| Abstract | ObjectivesAutoantibodies are used clinically to phenotype and subset patients with autoimmune rheumatic diseases. We detected a novel 60 kDa autoantibody specificity by immunoblotting using a dermatomyositis (DM) patient's serum. Our objective was to identify the targeted autoantigen and to evaluate disease specificity and clinical significance of this new autoantibody.MethodsA new 60 kDa specificity was detected by immunoblotting HeLa cell lysates. The targeted autoantigen was identified as poly(U)-binding-splicing factor 60 kDa (PUF60) using (i) a human protein array and (ii) two-dimensional gel electrophoresis and liquid chromatography tandem mass spectrometry peptide sequencing. Anti-PUF60 antibodies were assayed by ELISA using sera from patients with primary Sjögren's syndrome (SS; n=84), systemic lupus erythematosus (SLE; n=71), DM (n=267), polymyositis (n=45), inclusion body myositis (n=45) and healthy controls (n=38).ResultsPUF60 was identified as a new autoantigen. Anti-PUF60 antibodies were present in 25/84 (30%) patients with SS, 6/71 (8.5%) patients with SLE and 2/38 (5.0%) control subjects (SS vs controls, p=0.002; SLE vs controls, p=0.711). Anti-PUF60 antibodies were present in 48/267 (18.0%) patients with DM versus 4/45 (8.9%) and 5/45 (11.1%) patients with inclusion body myositis and polymyositis, respectively. The antibody was significantly associated with anti-Ro52 antibodies, rheumatoid factor and hyperglobulinemia in the patients with primary SS. In patients with DM, the antibody was associated with anti-transcription intermediary factor 1 gamma seropositivity and Caucasian race.ConclusionsPUF60 represents a novel autoantigen in patients with SS and DM. PUF60 antibodies are associated with distinct clinical features and different immune responses in different diseases. |
|---|---|
| AbstractList | ObjectivesAutoantibodies are used clinically to phenotype and subset patients with autoimmune rheumatic diseases. We detected a novel 60 kDa autoantibody specificity by immunoblotting using a dermatomyositis (DM) patient's serum. Our objective was to identify the targeted autoantigen and to evaluate disease specificity and clinical significance of this new autoantibody.MethodsA new 60 kDa specificity was detected by immunoblotting HeLa cell lysates. The targeted autoantigen was identified as poly(U)-binding-splicing factor 60 kDa (PUF60) using (i) a human protein array and (ii) two-dimensional gel electrophoresis and liquid chromatography tandem mass spectrometry peptide sequencing. Anti-PUF60 antibodies were assayed by ELISA using sera from patients with primary Sjögren's syndrome (SS; n=84), systemic lupus erythematosus (SLE; n=71), DM (n=267), polymyositis (n=45), inclusion body myositis (n=45) and healthy controls (n=38).ResultsPUF60 was identified as a new autoantigen. Anti-PUF60 antibodies were present in 25/84 (30%) patients with SS, 6/71 (8.5%) patients with SLE and 2/38 (5.0%) control subjects (SS vs controls, p=0.002; SLE vs controls, p=0.711). Anti-PUF60 antibodies were present in 48/267 (18.0%) patients with DM versus 4/45 (8.9%) and 5/45 (11.1%) patients with inclusion body myositis and polymyositis, respectively. The antibody was significantly associated with anti-Ro52 antibodies, rheumatoid factor and hyperglobulinemia in the patients with primary SS. In patients with DM, the antibody was associated with anti-transcription intermediary factor 1 gamma seropositivity and Caucasian race.ConclusionsPUF60 represents a novel autoantigen in patients with SS and DM. PUF60 antibodies are associated with distinct clinical features and different immune responses in different diseases. Autoantibodies are used clinically to phenotype and subset patients with autoimmune rheumatic diseases. We detected a novel 60 kDa autoantibody specificity by immunoblotting using a dermatomyositis (DM) patient's serum. Our objective was to identify the targeted autoantigen and to evaluate disease specificity and clinical significance of this new autoantibody.OBJECTIVESAutoantibodies are used clinically to phenotype and subset patients with autoimmune rheumatic diseases. We detected a novel 60 kDa autoantibody specificity by immunoblotting using a dermatomyositis (DM) patient's serum. Our objective was to identify the targeted autoantigen and to evaluate disease specificity and clinical significance of this new autoantibody.A new 60 kDa specificity was detected by immunoblotting HeLa cell lysates. The targeted autoantigen was identified as poly(U)-binding-splicing factor 60 kDa (PUF60) using (i) a human protein array and (ii) two-dimensional gel electrophoresis and liquid chromatography tandem mass spectrometry peptide sequencing. Anti-PUF60 antibodies were assayed by ELISA using sera from patients with primary Sjögren's syndrome (SS; n=84), systemic lupus erythematosus (SLE; n=71), DM (n=267), polymyositis (n=45), inclusion body myositis (n=45) and healthy controls (n=38).METHODSA new 60 kDa specificity was detected by immunoblotting HeLa cell lysates. The targeted autoantigen was identified as poly(U)-binding-splicing factor 60 kDa (PUF60) using (i) a human protein array and (ii) two-dimensional gel electrophoresis and liquid chromatography tandem mass spectrometry peptide sequencing. Anti-PUF60 antibodies were assayed by ELISA using sera from patients with primary Sjögren's syndrome (SS; n=84), systemic lupus erythematosus (SLE; n=71), DM (n=267), polymyositis (n=45), inclusion body myositis (n=45) and healthy controls (n=38).PUF60 was identified as a new autoantigen. Anti-PUF60 antibodies were present in 25/84 (30%) patients with SS, 6/71 (8.5%) patients with SLE and 2/38 (5.0%) control subjects (SS vs controls, p=0.002; SLE vs controls, p=0.711). Anti-PUF60 antibodies were present in 48/267 (18.0%) patients with DM versus 4/45 (8.9%) and 5/45 (11.1%) patients with inclusion body myositis and polymyositis, respectively. The antibody was significantly associated with anti-Ro52 antibodies, rheumatoid factor and hyperglobulinemia in the patients with primary SS. In patients with DM, the antibody was associated with anti-transcription intermediary factor 1 gamma seropositivity and Caucasian race.RESULTSPUF60 was identified as a new autoantigen. Anti-PUF60 antibodies were present in 25/84 (30%) patients with SS, 6/71 (8.5%) patients with SLE and 2/38 (5.0%) control subjects (SS vs controls, p=0.002; SLE vs controls, p=0.711). Anti-PUF60 antibodies were present in 48/267 (18.0%) patients with DM versus 4/45 (8.9%) and 5/45 (11.1%) patients with inclusion body myositis and polymyositis, respectively. The antibody was significantly associated with anti-Ro52 antibodies, rheumatoid factor and hyperglobulinemia in the patients with primary SS. In patients with DM, the antibody was associated with anti-transcription intermediary factor 1 gamma seropositivity and Caucasian race.PUF60 represents a novel autoantigen in patients with SS and DM. PUF60 antibodies are associated with distinct clinical features and different immune responses in different diseases.CONCLUSIONSPUF60 represents a novel autoantigen in patients with SS and DM. PUF60 antibodies are associated with distinct clinical features and different immune responses in different diseases. Objectives Autoantibodies are used clinically to phenotype and subset patients with autoimmune rheumatic diseases. We detected a novel 60 kDa autoantibody specificity by immunoblotting using a dermatomyositis (DM) patient's serum. Our objective was to identify the targeted autoantigen and to evaluate disease specificity and clinical significance of this new autoantibody. Methods A new 60 kDa specificity was detected by immunoblotting HeLa cell lysates. The targeted autoantigen was identified as poly(U)-binding-splicing factor 60 kDa (PUF60) using (i) a human protein array and (ii) two-dimensional gel electrophoresis and liquid chromatography tandem mass spectrometry peptide sequencing. Anti-PUF60 antibodies were assayed by ELISA using sera from patients with primary Sjögren's syndrome (SS; n=84), systemic lupus erythematosus (SLE; n=71), DM (n=267), polymyositis (n=45), inclusion body myositis (n=45) and healthy controls (n=38). Results PUF60 was identified as a new autoantigen. Anti-PUF60 antibodies were present in 25/84 (30%) patients with SS, 6/71 (8.5%) patients with SLE and 2/38 (5.0%) control subjects (SS vs controls, p=0.002; SLE vs controls, p=0.711). Anti-PUF60 antibodies were present in 48/267 (18.0%) patients with DM versus 4/45 (8.9%) and 5/45 (11.1%) patients with inclusion body myositis and polymyositis, respectively. The antibody was significantly associated with anti-Ro52 antibodies, rheumatoid factor and hyperglobulinemia in the patients with primary SS. In patients with DM, the antibody was associated with anti-transcription intermediary factor 1 gamma seropositivity and Caucasian race. Conclusions PUF60 represents a novel autoantigen in patients with SS and DM. PUF60 antibodies are associated with distinct clinical features and different immune responses in different diseases. Autoantibodies are used clinically to phenotype and subset patients with autoimmune rheumatic diseases. We detected a novel 60 kDa autoantibody specificity by immunoblotting using a dermatomyositis (DM) patient's serum. Our objective was to identify the targeted autoantigen and to evaluate disease specificity and clinical significance of this new autoantibody. A new 60 kDa specificity was detected by immunoblotting HeLa cell lysates. The targeted autoantigen was identified as poly(U)-binding-splicing factor 60 kDa (PUF60) using (i) a human protein array and (ii) two-dimensional gel electrophoresis and liquid chromatography tandem mass spectrometry peptide sequencing. Anti-PUF60 antibodies were assayed by ELISA using sera from patients with primary Sjögren's syndrome (SS; n=84), systemic lupus erythematosus (SLE; n=71), DM (n=267), polymyositis (n=45), inclusion body myositis (n=45) and healthy controls (n=38). PUF60 was identified as a new autoantigen. Anti-PUF60 antibodies were present in 25/84 (30%) patients with SS, 6/71 (8.5%) patients with SLE and 2/38 (5.0%) control subjects (SS vs controls, p=0.002; SLE vs controls, p=0.711). Anti-PUF60 antibodies were present in 48/267 (18.0%) patients with DM versus 4/45 (8.9%) and 5/45 (11.1%) patients with inclusion body myositis and polymyositis, respectively. The antibody was significantly associated with anti-Ro52 antibodies, rheumatoid factor and hyperglobulinemia in the patients with primary SS. In patients with DM, the antibody was associated with anti-transcription intermediary factor 1 gamma seropositivity and Caucasian race. PUF60 represents a novel autoantigen in patients with SS and DM. PUF60 antibodies are associated with distinct clinical features and different immune responses in different diseases. |
| Author | Rieger, Kerri E Rosen, Antony Mammen, Andrew L Petri, Michelle Fiorentino, David F Presby, Matthew Soloski, Mark Christopher-Stine, Lisa Baer, Alan N Casciola-Rosen, Livia |
| AuthorAffiliation | 3 Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA 1 Department of Dermatology, Stanford University School of Medicine, Redwood City, CA, USA 2 Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA 4 Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA 5 Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD |
| AuthorAffiliation_xml | – name: 2 Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA – name: 1 Department of Dermatology, Stanford University School of Medicine, Redwood City, CA, USA – name: 4 Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA – name: 3 Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA – name: 5 Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD |
| Author_xml | – sequence: 1 givenname: David F surname: Fiorentino fullname: Fiorentino, David F email: lcr@jhmi.edu organization: Department of Dermatology, Stanford University School of Medicine, Redwood City, California, USA – sequence: 2 givenname: Matthew surname: Presby fullname: Presby, Matthew email: lcr@jhmi.edu organization: Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 3 givenname: Alan N surname: Baer fullname: Baer, Alan N email: lcr@jhmi.edu organization: Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 4 givenname: Michelle surname: Petri fullname: Petri, Michelle email: lcr@jhmi.edu organization: Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 5 givenname: Kerri E surname: Rieger fullname: Rieger, Kerri E email: lcr@jhmi.edu organization: Department of Pathology, Stanford University School of Medicine, Stanford, California, USA – sequence: 6 givenname: Mark surname: Soloski fullname: Soloski, Mark email: lcr@jhmi.edu organization: Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 7 givenname: Antony surname: Rosen fullname: Rosen, Antony email: lcr@jhmi.edu organization: Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 8 givenname: Andrew L surname: Mammen fullname: Mammen, Andrew L email: lcr@jhmi.edu organization: Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA – sequence: 9 givenname: Lisa surname: Christopher-Stine fullname: Christopher-Stine, Lisa email: lcr@jhmi.edu organization: Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA – sequence: 10 givenname: Livia surname: Casciola-Rosen fullname: Casciola-Rosen, Livia email: lcr@jhmi.edu organization: Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26253095$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkd9qFDEUxoNU7Hb1FTTghd6M5s9MkhEUpFgVCgra65DJnNnNsknWJKPsi_kCvphZtpbaq0JIOOT3nZwv3xk6CTEAQs8oeUUpF69NCGkNsx9dbhihXd1kR_oHaEFboWolyAlaEEJ40_ZCnqKznDe1JIqqR-iUCdZx0ncLZL9eXQjyBhu8S9G7AKHgAL9wMWkFBccJlzVgM5fovJ8D4AR5F0MG7AIeIXlTot_H7IrL2IQRf9v8-b1KEF5knPdhrE3hMXo4mW2GJ9fnEl1dfPh-_qm5_PLx8_n7y2bourY0dOwpH-zIQMrOqpFbDoxMDGDiUzVJpkHJUVHJpo5yyQYQkzRCWcKsUqTlS_Tu2Hc3Dx5GW70ks9W75LxJex2N0__fBLfWq_hTt4opXtcSvbxukOKPGXLR3mUL260JEOesqVSq46LnoqLP76CbOKdQ7VWq56r-r5SVenp7optR_v1_BeQRsCnmnGC6QSjRh6T1raT1IWl9TLoq395RWldMcfFgzW3voWdH_eA39370L6SNxlk |
| CODEN | ARDIAO |
| CitedBy_id | crossref_primary_10_1007_s10067_016_3453_0 crossref_primary_10_1007_s10067_018_4031_4 crossref_primary_10_1002_art_42667 crossref_primary_10_1111_nan_12380 crossref_primary_10_1186_s12920_018_0421_3 crossref_primary_10_1038_nrdp_2016_47 crossref_primary_10_1016_j_autrev_2018_09_003 crossref_primary_10_1111_cas_14767 crossref_primary_10_1161_CIRCULATIONAHA_121_056038 crossref_primary_10_1002_art_41602 crossref_primary_10_3390_jcm9072299 crossref_primary_10_3389_fimmu_2022_1003054 crossref_primary_10_1080_14737175_2019_1572507 crossref_primary_10_1097_BOR_0000000000000536 crossref_primary_10_3390_ijms242417341 crossref_primary_10_1097_BOR_0000000000000742 crossref_primary_10_1002_pmic_201600104 crossref_primary_10_3389_fimmu_2022_831849 crossref_primary_10_1111_cas_14024 crossref_primary_10_1155_2018_1246818 crossref_primary_10_1016_j_jns_2021_117421 crossref_primary_10_1097_BOR_0000000000000330 crossref_primary_10_3389_fimmu_2021_679613 crossref_primary_10_1016_j_berh_2016_04_007 |
| Cites_doi | 10.1097/BOR.0b013e328358bd85 10.1002/art.22164 10.1002/acr.22600 10.1017/S1355838299991938 10.1016/S1097-2765(00)80428-1 10.1158/0008-5472.CAN-04-4459 10.1002/art.1780251101 10.1371/journal.pone.0009983 10.1002/art.33379 10.1056/NEJM197502202920807 10.1084/jem.20041367 10.1016/j.jaut.2013.11.001 10.1002/art.22862 10.1056/NEJM197502132920706 10.1002/acr.21992 10.1002/art.27370 10.1016/j.lpm.2012.05.022 10.1016/j.jaut.2009.11.013 10.1111/j.1365-2796.2009.02102.x 10.1016/j.autrev.2012.05.011 10.1016/j.jaad.2014.12.009 10.1186/1755-8794-5-14 10.3109/s10165-012-0663-4 10.1002/art.30156 10.1017/S1355838200990277 10.1016/j.autrev.2009.02.010 10.1371/journal.pone.0000538 10.1002/art.1780400928 10.1002/art.33403 10.1002/art.24547 10.1126/science.1246886 10.1016/j.autrev.2010.09.001 10.1101/gad.1603907 10.1016/j.autrev.2010.09.005 10.1136/jnnp-2013-305690 10.1097/MD.0b013e31829d08f9 10.1002/art.38093 10.1212/WNL.0000000000000642 10.1016/S0733-8635(02)00021-9 10.1093/rheumatology/kep375 10.1136/ard.61.6.554 10.1002/art.27549 10.2144/99274rr02 |
| ContentType | Journal Article |
| Copyright | Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing |
| Copyright_xml | – notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing – notice: Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 88I 8AF 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI BTHHO CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9- K9. LK8 M0R M0S M1P M2P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM |
| DOI | 10.1136/annrheumdis-2015-207509 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Database ProQuest Central Natural Science Collection BMJ Journals ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Consumer Health Database ProQuest Health & Medical Collection Proquest Medical Database Science Database (subscription) Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition BMJ Journals ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic ProQuest Central Student MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1468-2060 |
| EndPage | 1151 |
| ExternalDocumentID | PMC4828328 4078419551 26253095 10_1136_annrheumdis_2015_207509 annrheumdis |
| Genre | Multicenter Study Journal Article |
| GeographicLocations | United States--US |
| GeographicLocations_xml | – name: United States--US |
| GrantInformation_xml | – fundername: NIDCR NIH HHS grantid: R01 DE012354 – fundername: NIAMS NIH HHS grantid: P30 AR070254 – fundername: NIAMS NIH HHS grantid: R01 AR043727 – fundername: NIAMS NIH HHS grantid: R01 AR044684 – fundername: NIAMS NIH HHS grantid: P30 AR053503 |
| GroupedDBID | --- .55 .GJ .VT 169 23M 2WC 39C 3O- 4.4 40O 53G 5GY 5RE 5VS 6J9 7X7 7~S 88E 88I 8AF 8FE 8FH 8FI 8FJ 8R4 8R5 AAHLL AAKAS AAOJX AAWJN AAWTL AAXUO ABAAH ABJNI ABKDF ABMQD ABOCM ABTFR ABUWG ABVAJ ACGFO ACGFS ACGOD ACGTL ACHTP ACMFJ ACOAB ACOFX ACPRK ACQSR ACTZY ADBBV ADCEG ADFRT ADUGQ ADZCM AEKJL AENEX AFKRA AFWFF AGQPQ AHMBA AHNKE AHQMW AJYBZ AKKEP ALIPV ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BKNYI BLJBA BOMFT BPHCQ BTFSW BTHHO BVXVI C1A C45 CAG CCPQU COF CS3 CXRWF DIK DWQXO E3Z EBS EJD F5P FDB FYUFA GNUQQ H13 HAJ HCIFZ HMCUK HYE HZ~ IAO IEA IHR INH INR IOF ITC J5H K9- KQ8 L7B LK8 M0R M1P M2P M7P N9A NTWIH NXWIF O9- OK1 OVD P2P PHGZT PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 RWL RXW TAE TEORI TR2 UAW UKHRP UYXKK V24 VM9 VVN W2D W8F WH7 WOQ X6Y X7M YFH YOC YQY ZGI ZXP AAFWJ AALRI AAYXX CITATION PHGZM 0R~ 3V. CGR CUY CVF ECM EIF FRP IGG NPM PKN RHF 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-b554t-1d913bcd2e775c8d3c3e20f2eef3f2010fb87d8172f51372be6f7a68c02c88043 |
| IEDL.DBID | 7X7 |
| ISSN | 0003-4967 1468-2060 |
| IngestDate | Thu Aug 21 14:02:33 EDT 2025 Fri Jul 11 10:41:46 EDT 2025 Fri Jul 25 11:16:28 EDT 2025 Sat Feb 15 01:21:15 EST 2025 Tue Jul 01 04:18:00 EDT 2025 Thu Apr 24 23:10:23 EDT 2025 Thu Apr 24 23:06:54 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Systemic Lupus Erythematosus Autoantibodies Sjøgren's Syndrome Dermatomyositis |
| Language | English |
| License | Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b554t-1d913bcd2e775c8d3c3e20f2eef3f2010fb87d8172f51372be6f7a68c02c88043 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://doi.org/10.1136/annrheumdis-2015-207509 |
| PMID | 26253095 |
| PQID | 1793825377 |
| PQPubID | 2041045 |
| PageCount | 7 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4828328 proquest_miscellaneous_1788536936 proquest_journals_1793825377 pubmed_primary_26253095 crossref_primary_10_1136_annrheumdis_2015_207509 crossref_citationtrail_10_1136_annrheumdis_2015_207509 bmj_primary_10_1136_annrheumdis_2015_207509 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2016-06-01 |
| PublicationDateYYYYMMDD | 2016-06-01 |
| PublicationDate_xml | – month: 06 year: 2016 text: 2016-06-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Kidlington |
| PublicationTitle | Annals of the rheumatic diseases |
| PublicationTitleAlternate | Ann Rheum Dis |
| PublicationYear | 2016 |
| Publisher | Elsevier Limited |
| Publisher_xml | – name: Elsevier Limited |
| References | Casciola-Rosen, Mammen 2012; 24 Defendenti, Atzeni, Spina 2011; 10 Betteridge, Gunawardena, North 2007; 56 Mammen, Chung, Christopher-Stine 2011; 63 Reed, Dudek, Osborne 2010; 62 Sato, Kuwana, Fujita 2013; 23 Lloyd, Mammen, Amato 2014; 83 Bohan, Peter 1975; 292 Tan, Cohen, Fries 1982; 25 Schulte-Pelkum, Fritzler, Mahler 2009; 8 Fujimoto, Hamaguchi, Kaji 2012; 64 Casciola-Rosen, Nagaraju, Plotz 2005; 201 Trallero-Araguas, Rodrigo-Pendas, Selva-O'Callaghan 2012; 64 Lloyd, Christopher-Stine, Pinal-Fernandez 2015 Targoff, Trieu, Levy-Neto 2006; 54 Hochberg 1997; 40 Kyriakidis, Kapsogeorgou, Tzioufas 2014; 51 Vitali, Bombardieri, Jonsson 2002; 61 Sontheimer 2002; 20 Hall, Casciola-Rosen, Samedy 2013; 65 Ramakrishna, Williams, Boyle 2010; 5 Hernandez-Molina, Leal-Alegre, Michel-Peregrina 2011; 10 Nakashima, Imura, Kobayashi 2010; 49 Fiorentino, Kuo, Chung 2015; 72 Shah, Rosen, Hummers 2010; 62 Matsushita, Tomonaga, Shimada 2006; 66 Tzioufas, Tatouli, Moutsopoulos 2012; 41 Bouffard, Briere, Wellinger 1999; 27 Joseph, Darrah, Shah 2014; 343 Rider, Shah, Mamyrova 2013; 92 Hogg, Collins 2007; 21 Gunawardena, Wedderburn, Chinoy 2009; 60 Bouffard, Barbar, Briere 2000; 6 Hoffmann, Trembleau, Muller 2010; 34 Liu, He, Collins 2000; 5 Page-McCaw, Amonlirdviman, Sharp 1999; 5 Hastings, Allemand, Duelli 2007; 2 Fiorentino, Chung, Christopher-Stine 2013; 65 Rosen, Casciola-Rosen 2009; 265 Cheng, Wang, Yang 2012; 5 Mehra, Walker, Patterson 2013; 12 Brady, Squier, Hilton-Jones 2013; 84 Nakashima (10.1136/annrheumdis-2015-207509_bib5) 2010; 49 Shah (10.1136/annrheumdis-2015-207509_bib17) 2010; 62 Fiorentino (10.1136/annrheumdis-2015-207509_bib30) 2015; 72 Liu (10.1136/annrheumdis-2015-207509_bib34) 2000; 5 Gunawardena (10.1136/annrheumdis-2015-207509_bib10) 2009; 60 Defendenti (10.1136/annrheumdis-2015-207509_bib14) 2011; 10 Hall (10.1136/annrheumdis-2015-207509_bib27) 2013; 65 Tzioufas (10.1136/annrheumdis-2015-207509_bib11) 2012; 41 Schulte-Pelkum (10.1136/annrheumdis-2015-207509_bib42) 2009; 8 Hernandez-Molina (10.1136/annrheumdis-2015-207509_bib12) 2011; 10 Lloyd (10.1136/annrheumdis-2015-207509_bib22) 2014; 83 Hogg (10.1136/annrheumdis-2015-207509_bib37) 2007; 21 Kyriakidis (10.1136/annrheumdis-2015-207509_bib1) 2014; 51 Brady (10.1136/annrheumdis-2015-207509_bib23) 2013; 84 Sato (10.1136/annrheumdis-2015-207509_bib6) 2013; 23 Joseph (10.1136/annrheumdis-2015-207509_bib18) 2014; 343 Tan (10.1136/annrheumdis-2015-207509_bib25) 1982; 25 Reed (10.1136/annrheumdis-2015-207509_bib13) 2010; 62 Matsushita (10.1136/annrheumdis-2015-207509_bib41) 2006; 66 Casciola-Rosen (10.1136/annrheumdis-2015-207509_bib3) 2012; 24 Trallero-Araguas (10.1136/annrheumdis-2015-207509_bib16) 2012; 64 Page-McCaw (10.1136/annrheumdis-2015-207509_bib32) 1999; 5 Bohan (10.1136/annrheumdis-2015-207509_bib20) 1975; 292 Bohan (10.1136/annrheumdis-2015-207509_bib24) 1975; 292 Rider (10.1136/annrheumdis-2015-207509_bib4) 2013; 92 Betteridge (10.1136/annrheumdis-2015-207509_bib9) 2007; 56 Hochberg (10.1136/annrheumdis-2015-207509_bib26) 1997; 40 Cheng (10.1136/annrheumdis-2015-207509_bib39) 2012; 5 Mammen (10.1136/annrheumdis-2015-207509_bib28) 2011; 63 Sontheimer (10.1136/annrheumdis-2015-207509_bib21) 2002; 20 10.1136/annrheumdis-2015-207509_bib29 Fiorentino (10.1136/annrheumdis-2015-207509_bib15) 2013; 65 Targoff (10.1136/annrheumdis-2015-207509_bib7) 2006; 54 Hastings (10.1136/annrheumdis-2015-207509_bib33) 2007; 2 Bouffard (10.1136/annrheumdis-2015-207509_bib35) 1999; 27 Mehra (10.1136/annrheumdis-2015-207509_bib2) 2013; 12 Casciola-Rosen (10.1136/annrheumdis-2015-207509_bib31) 2005; 201 Hoffmann (10.1136/annrheumdis-2015-207509_bib38) 2010; 34 Bouffard (10.1136/annrheumdis-2015-207509_bib36) 2000; 6 Rosen (10.1136/annrheumdis-2015-207509_bib43) 2009; 265 Vitali (10.1136/annrheumdis-2015-207509_bib19) 2002; 61 Fujimoto (10.1136/annrheumdis-2015-207509_bib8) 2012; 64 Ramakrishna (10.1136/annrheumdis-2015-207509_bib40) 2010; 5 |
| References_xml | – volume: 24 start-page: 602 year: 2012 article-title: Myositis autoantibodies publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0b013e328358bd85 – volume: 54 start-page: S518 year: 2006 article-title: Autoantibodies to transcriptional intermediary factor 1-gamma (TIF1-g) in dermatomyositis [abstract] publication-title: Arthritis Rheum doi: 10.1002/art.22164 – year: 2015 article-title: Cytosolic 5′-nucleotidase 1A is a common target of circulating autoantibodies in several autoimmune diseases publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.22600 – volume: 5 start-page: 1548 year: 1999 article-title: PUF60: a novel U2AF65-related splicing activity publication-title: RNA doi: 10.1017/S1355838299991938 – volume: 5 start-page: 331 year: 2000 article-title: The FBP interacting repressor targets TFIIH to inhibit activated transcription publication-title: Mol Cell doi: 10.1016/S1097-2765(00)80428-1 – volume: 66 start-page: 1409 year: 2006 article-title: An essential role of alternative splicing of c-myc suppressor FUSE-binding protein-interacting repressor in carcinogenesis publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-04-4459 – volume: 25 start-page: 1271 year: 1982 article-title: The 1982 revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.1780251101 – volume: 5 start-page: e9983 year: 2010 article-title: Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis publication-title: PLoS ONE doi: 10.1371/journal.pone.0009983 – volume: 64 start-page: 523 year: 2012 article-title: Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis publication-title: Arthritis Rheum doi: 10.1002/art.33379 – volume: 292 start-page: 403 year: 1975 article-title: Polymyositis and dermatomyositis (second of two parts) publication-title: N Engl J Med doi: 10.1056/NEJM197502202920807 – volume: 201 start-page: 591 year: 2005 article-title: Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy publication-title: J Exp Med doi: 10.1084/jem.20041367 – volume: 51 start-page: 67 year: 2014 article-title: A comprehensive review of autoantibodies in primary Sjogren's syndrome: clinical phenotypes and regulatory mechanisms publication-title: J Autoimmun doi: 10.1016/j.jaut.2013.11.001 – volume: 56 start-page: 3132 year: 2007 article-title: Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis publication-title: Arthritis Rheum doi: 10.1002/art.22862 – volume: 292 start-page: 344 year: 1975 article-title: Polymyositis and dermatomyositis (first of two parts) publication-title: N Engl J Med doi: 10.1056/NEJM197502132920706 – volume: 65 start-page: 1307 year: 2013 article-title: Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.21992 – volume: 62 start-page: 1448 year: 2010 article-title: Reactivity with dichotomous determinants of Ro 60 stratifies autoantibody responses in lupus and primary Sjogren's syndrome publication-title: Arthritis Rheum doi: 10.1002/art.27370 – volume: 41 start-page: e451 issue: (9 Pt 2) year: 2012 article-title: Autoantibodies in Sjogren's syndrome: clinical presentation and regulatory mechanisms publication-title: Presse Med doi: 10.1016/j.lpm.2012.05.022 – volume: 27 start-page: 790 year: 1999 article-title: Identification of ribonucleoprotein (RNP)-specific protein interactions using a yeast RNP interaction trap assay (RITA) publication-title: Biotechniques – volume: 34 start-page: J178 year: 2010 article-title: Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential publication-title: J Autoimmun doi: 10.1016/j.jaut.2009.11.013 – volume: 265 start-page: 625 year: 2009 article-title: Autoantigens in systemic autoimmunity: critical partner in pathogenesis publication-title: J Intern Med doi: 10.1111/j.1365-2796.2009.02102.x – volume: 12 start-page: 340 year: 2013 article-title: Autoantibodies in systemic sclerosis publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2012.05.011 – volume: 72 start-page: 449 year: 2015 article-title: Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1gamma antibodies in adults with dermatomyositis publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2014.12.009 – volume: 5 start-page: 14 year: 2012 article-title: Identification of genes with a correlation between copy number and expression in gastric cancer publication-title: BMC Med Genomics doi: 10.1186/1755-8794-5-14 – volume: 23 start-page: 496 year: 2013 article-title: Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease publication-title: Mod Rheumatol doi: 10.3109/s10165-012-0663-4 – volume: 63 start-page: 713 year: 2011 article-title: Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy publication-title: Arthritis Rheum doi: 10.1002/art.30156 – volume: 6 start-page: 66 year: 2000 article-title: Interaction cloning and characterization of RoBPI, a novel protein binding to human Ro ribonucleoproteins publication-title: RNA doi: 10.1017/S1355838200990277 – volume: 8 start-page: 632 year: 2009 article-title: Latest update on the Ro/SS-A autoantibody system publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2009.02.010 – volume: 2 start-page: e538 year: 2007 article-title: Control of pre-mRNA splicing by the general splicing factors PUF60 and U2AF(65) publication-title: PLoS ONE doi: 10.1371/journal.pone.0000538 – volume: 40 start-page: 1725 year: 1997 article-title: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.1780400928 – volume: 64 start-page: 513 year: 2012 article-title: Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins publication-title: Arthritis Rheum doi: 10.1002/art.33403 – volume: 60 start-page: 1807 year: 2009 article-title: Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis publication-title: Arthritis Rheum doi: 10.1002/art.24547 – volume: 343 start-page: 152 year: 2014 article-title: Association of the autoimmune disease scleroderma with an immunologic response to cancer publication-title: Science doi: 10.1126/science.1246886 – volume: 10 start-page: 123 year: 2011 article-title: The meaning of anti-Ro and anti-La antibodies in primary Sjogren's syndrome publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2010.09.001 – volume: 21 start-page: 3067 year: 2007 article-title: Human Y5 RNA specializes a Ro ribonucleoprotein for 5S ribosomal RNA quality control publication-title: Genes Dev doi: 10.1101/gad.1603907 – volume: 10 start-page: 150 year: 2011 article-title: Clinical and laboratory aspects of Ro/SSA-52 autoantibodies publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2010.09.005 – volume: 84 start-page: 1240 year: 2013 article-title: Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2013-305690 – volume: 92 start-page: 223 year: 2013 article-title: The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies publication-title: Medicine doi: 10.1097/MD.0b013e31829d08f9 – volume: 65 start-page: 2954 year: 2013 article-title: Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1gamma publication-title: Arthritis Rheum doi: 10.1002/art.38093 – volume: 83 start-page: 426 year: 2014 article-title: Evaluation and construction of diagnostic criteria for inclusion body myositis publication-title: Neurology doi: 10.1212/WNL.0000000000000642 – volume: 20 start-page: 387 year: 2002 article-title: Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects publication-title: Dermatol Clin doi: 10.1016/S0733-8635(02)00021-9 – volume: 49 start-page: 433 year: 2010 article-title: The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody publication-title: Rheumatology doi: 10.1093/rheumatology/kep375 – volume: 61 start-page: 554 year: 2002 article-title: Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group publication-title: Ann Rheum Dis doi: 10.1136/ard.61.6.554 – volume: 62 start-page: 2787 year: 2010 article-title: Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies publication-title: Arthritis Rheum doi: 10.1002/art.27549 – volume: 61 start-page: 554 year: 2002 ident: 10.1136/annrheumdis-2015-207509_bib19 article-title: Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group publication-title: Ann Rheum Dis doi: 10.1136/ard.61.6.554 – volume: 20 start-page: 387 year: 2002 ident: 10.1136/annrheumdis-2015-207509_bib21 article-title: Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects publication-title: Dermatol Clin doi: 10.1016/S0733-8635(02)00021-9 – volume: 5 start-page: 1548 year: 1999 ident: 10.1136/annrheumdis-2015-207509_bib32 article-title: PUF60: a novel U2AF65-related splicing activity publication-title: RNA doi: 10.1017/S1355838299991938 – volume: 265 start-page: 625 year: 2009 ident: 10.1136/annrheumdis-2015-207509_bib43 article-title: Autoantigens in systemic autoimmunity: critical partner in pathogenesis publication-title: J Intern Med doi: 10.1111/j.1365-2796.2009.02102.x – volume: 5 start-page: e9983 year: 2010 ident: 10.1136/annrheumdis-2015-207509_bib40 article-title: Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis publication-title: PLoS ONE doi: 10.1371/journal.pone.0009983 – volume: 62 start-page: 2787 year: 2010 ident: 10.1136/annrheumdis-2015-207509_bib17 article-title: Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies publication-title: Arthritis Rheum doi: 10.1002/art.27549 – volume: 60 start-page: 1807 year: 2009 ident: 10.1136/annrheumdis-2015-207509_bib10 article-title: Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis publication-title: Arthritis Rheum doi: 10.1002/art.24547 – volume: 65 start-page: 1307 year: 2013 ident: 10.1136/annrheumdis-2015-207509_bib27 article-title: Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.21992 – volume: 84 start-page: 1240 year: 2013 ident: 10.1136/annrheumdis-2015-207509_bib23 article-title: Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2013-305690 – volume: 34 start-page: J178 year: 2010 ident: 10.1136/annrheumdis-2015-207509_bib38 article-title: Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential publication-title: J Autoimmun doi: 10.1016/j.jaut.2009.11.013 – ident: 10.1136/annrheumdis-2015-207509_bib29 doi: 10.1002/acr.22600 – volume: 292 start-page: 403 year: 1975 ident: 10.1136/annrheumdis-2015-207509_bib24 article-title: Polymyositis and dermatomyositis (second of two parts) publication-title: N Engl J Med doi: 10.1056/NEJM197502202920807 – volume: 63 start-page: 713 year: 2011 ident: 10.1136/annrheumdis-2015-207509_bib28 article-title: Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy publication-title: Arthritis Rheum doi: 10.1002/art.30156 – volume: 62 start-page: 1448 year: 2010 ident: 10.1136/annrheumdis-2015-207509_bib13 article-title: Reactivity with dichotomous determinants of Ro 60 stratifies autoantibody responses in lupus and primary Sjogren's syndrome publication-title: Arthritis Rheum doi: 10.1002/art.27370 – volume: 24 start-page: 602 year: 2012 ident: 10.1136/annrheumdis-2015-207509_bib3 article-title: Myositis autoantibodies publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0b013e328358bd85 – volume: 92 start-page: 223 year: 2013 ident: 10.1136/annrheumdis-2015-207509_bib4 article-title: The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies publication-title: Medicine doi: 10.1097/MD.0b013e31829d08f9 – volume: 41 start-page: e451 issue: 9 Pt 2 year: 2012 ident: 10.1136/annrheumdis-2015-207509_bib11 article-title: Autoantibodies in Sjogren's syndrome: clinical presentation and regulatory mechanisms publication-title: Presse Med doi: 10.1016/j.lpm.2012.05.022 – volume: 5 start-page: 331 year: 2000 ident: 10.1136/annrheumdis-2015-207509_bib34 article-title: The FBP interacting repressor targets TFIIH to inhibit activated transcription publication-title: Mol Cell doi: 10.1016/S1097-2765(00)80428-1 – volume: 40 start-page: 1725 year: 1997 ident: 10.1136/annrheumdis-2015-207509_bib26 article-title: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.1780400928 – volume: 54 start-page: S518 year: 2006 ident: 10.1136/annrheumdis-2015-207509_bib7 article-title: Autoantibodies to transcriptional intermediary factor 1-gamma (TIF1-g) in dermatomyositis [abstract] publication-title: Arthritis Rheum – volume: 83 start-page: 426 year: 2014 ident: 10.1136/annrheumdis-2015-207509_bib22 article-title: Evaluation and construction of diagnostic criteria for inclusion body myositis publication-title: Neurology doi: 10.1212/WNL.0000000000000642 – volume: 66 start-page: 1409 year: 2006 ident: 10.1136/annrheumdis-2015-207509_bib41 article-title: An essential role of alternative splicing of c-myc suppressor FUSE-binding protein-interacting repressor in carcinogenesis publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-04-4459 – volume: 6 start-page: 66 year: 2000 ident: 10.1136/annrheumdis-2015-207509_bib36 article-title: Interaction cloning and characterization of RoBPI, a novel protein binding to human Ro ribonucleoproteins publication-title: RNA doi: 10.1017/S1355838200990277 – volume: 72 start-page: 449 year: 2015 ident: 10.1136/annrheumdis-2015-207509_bib30 article-title: Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1gamma antibodies in adults with dermatomyositis publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2014.12.009 – volume: 64 start-page: 523 year: 2012 ident: 10.1136/annrheumdis-2015-207509_bib16 article-title: Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis publication-title: Arthritis Rheum doi: 10.1002/art.33379 – volume: 56 start-page: 3132 year: 2007 ident: 10.1136/annrheumdis-2015-207509_bib9 article-title: Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis publication-title: Arthritis Rheum doi: 10.1002/art.22862 – volume: 343 start-page: 152 year: 2014 ident: 10.1136/annrheumdis-2015-207509_bib18 article-title: Association of the autoimmune disease scleroderma with an immunologic response to cancer publication-title: Science doi: 10.1126/science.1246886 – volume: 292 start-page: 344 year: 1975 ident: 10.1136/annrheumdis-2015-207509_bib20 article-title: Polymyositis and dermatomyositis (first of two parts) publication-title: N Engl J Med doi: 10.1056/NEJM197502132920706 – volume: 8 start-page: 632 year: 2009 ident: 10.1136/annrheumdis-2015-207509_bib42 article-title: Latest update on the Ro/SS-A autoantibody system publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2009.02.010 – volume: 51 start-page: 67 year: 2014 ident: 10.1136/annrheumdis-2015-207509_bib1 article-title: A comprehensive review of autoantibodies in primary Sjogren's syndrome: clinical phenotypes and regulatory mechanisms publication-title: J Autoimmun doi: 10.1016/j.jaut.2013.11.001 – volume: 65 start-page: 2954 year: 2013 ident: 10.1136/annrheumdis-2015-207509_bib15 article-title: Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1gamma publication-title: Arthritis Rheum doi: 10.1002/art.38093 – volume: 2 start-page: e538 year: 2007 ident: 10.1136/annrheumdis-2015-207509_bib33 article-title: Control of pre-mRNA splicing by the general splicing factors PUF60 and U2AF(65) publication-title: PLoS ONE doi: 10.1371/journal.pone.0000538 – volume: 12 start-page: 340 year: 2013 ident: 10.1136/annrheumdis-2015-207509_bib2 article-title: Autoantibodies in systemic sclerosis publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2012.05.011 – volume: 5 start-page: 14 year: 2012 ident: 10.1136/annrheumdis-2015-207509_bib39 article-title: Identification of genes with a correlation between copy number and expression in gastric cancer publication-title: BMC Med Genomics doi: 10.1186/1755-8794-5-14 – volume: 49 start-page: 433 year: 2010 ident: 10.1136/annrheumdis-2015-207509_bib5 article-title: The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody publication-title: Rheumatology doi: 10.1093/rheumatology/kep375 – volume: 10 start-page: 150 year: 2011 ident: 10.1136/annrheumdis-2015-207509_bib14 article-title: Clinical and laboratory aspects of Ro/SSA-52 autoantibodies publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2010.09.005 – volume: 27 start-page: 790 year: 1999 ident: 10.1136/annrheumdis-2015-207509_bib35 article-title: Identification of ribonucleoprotein (RNP)-specific protein interactions using a yeast RNP interaction trap assay (RITA) publication-title: Biotechniques doi: 10.2144/99274rr02 – volume: 21 start-page: 3067 year: 2007 ident: 10.1136/annrheumdis-2015-207509_bib37 article-title: Human Y5 RNA specializes a Ro ribonucleoprotein for 5S ribosomal RNA quality control publication-title: Genes Dev doi: 10.1101/gad.1603907 – volume: 10 start-page: 123 year: 2011 ident: 10.1136/annrheumdis-2015-207509_bib12 article-title: The meaning of anti-Ro and anti-La antibodies in primary Sjogren's syndrome publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2010.09.001 – volume: 201 start-page: 591 year: 2005 ident: 10.1136/annrheumdis-2015-207509_bib31 article-title: Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy publication-title: J Exp Med doi: 10.1084/jem.20041367 – volume: 23 start-page: 496 year: 2013 ident: 10.1136/annrheumdis-2015-207509_bib6 article-title: Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease publication-title: Mod Rheumatol doi: 10.3109/s10165-012-0663-4 – volume: 25 start-page: 1271 year: 1982 ident: 10.1136/annrheumdis-2015-207509_bib25 article-title: The 1982 revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.1780251101 – volume: 64 start-page: 513 year: 2012 ident: 10.1136/annrheumdis-2015-207509_bib8 article-title: Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins publication-title: Arthritis Rheum doi: 10.1002/art.33403 |
| SSID | ssj0000818 |
| Score | 2.3464153 |
| Snippet | ObjectivesAutoantibodies are used clinically to phenotype and subset patients with autoimmune rheumatic diseases. We detected a novel 60 kDa autoantibody... Autoantibodies are used clinically to phenotype and subset patients with autoimmune rheumatic diseases. We detected a novel 60 kDa autoantibody specificity by... Objectives Autoantibodies are used clinically to phenotype and subset patients with autoimmune rheumatic diseases. We detected a novel 60 kDa autoantibody... |
| SourceID | pubmedcentral proquest pubmed crossref bmj |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1145 |
| SubjectTerms | Adult Aged Antibodies Antigens Autoantibodies - blood Autoantigens - immunology Autoimmunity Biomarkers - blood Cancer Case-Control Studies Dermatomyositis - immunology Female Humans Lupus Male Middle Aged Patients Proteins Repressor Proteins - immunology Rheumatic diseases Rheumatology RNA polymerase RNA Splicing Factors - immunology Salivary Glands - immunology Scleroderma Sjogren's Syndrome - immunology Skin Skin - immunology |
| Title | PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome |
| URI | http://ard.bmj.com/content/75/6/1145.full https://www.ncbi.nlm.nih.gov/pubmed/26253095 https://www.proquest.com/docview/1793825377 https://www.proquest.com/docview/1788536936 https://pubmed.ncbi.nlm.nih.gov/PMC4828328 |
| Volume | 75 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB5BKyEuiDeBUhkJiQOKSGLHdrggQF1VSK0qYKW9RfFL3Yp1yiZ74I_xB_hjjBNny4IEXHKI7TzG45lvPOMZgOeCGWpQ7qVU6SZlrBCpalieSuVoZShX2gZD8eSUH8_Zh0W5iBtuXQyrnGTiIKhNq8Me-avASGjNUCHeXH5NQ9Wo4F2NJTSuw35IXRZCusRCXElimcupYh6ruIjxXTkdirysz-1mZZYdMkpe4iXoTtQwanWxq6P-AJ6_x0_-opBmt-FWRJLk7Tj1d-Ca9Xfhxkn0ld8DfTaf8ew1aQg-eoW3fE8QQ5Mx9pu0jiD2I82mb5fhjIgl6zFc1pKlJyYI7L5dfRtiujrSeEM-Xfz4jta5f9GRKc_BfZjPjj6_P05jSYVUIW7o09xUOc6KKawQpZaGamqLzBXWOuqCY9wpKYxEVOPKnIpCWe5Ew6XOCo0rndEHsOdbbx8BcSUaX6apqlI5pnilLHMlM1xlruKNlgm8RFLWl2PSjHowNuhwAHoifB0IX4-ET4BPJK91zE4eimR8-ffAbDvwv991MM1pHVdsV1_xVwLPts241oIDpfG23YQ-EtENryhP4OHIAtt3FmhIUsSrCYgd5th2CHm8d1v88nzI581kqBclH__9s57ATfwHPoapHcBev97YpwiIenU4cP0h7L87Oj37-BPhjg3t |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcEG8CBYwE4oCiJrFjO0gI8ehqS7urCrpSbyGO7XarblJ2s0L9Uxz5A_wxxnlsWZCASy85xM-MP88jHs8APBVMU418z6cqz3zGIuGrjIW-VJYmmnKVG2coDkd8MGYfDuKDNfjW3YVxbpUdT6wZtS5z94980wEJrRkqxOvTL77LGuVOV7sUGg0sdszZVzTZ5q-23-P6Poui_tb-u4HfZhXwFYrOyg91EuLEdGSEiHOpaU5NFNjIGEutOxu2SgotUbDbOKQiUoZbkXGZB1GOYGcU-70E64yiKdOD9bdbo72P57xfhrLL0ccSLlqPspDWaWVmR2Yx1ZM5QjOM8eGkNco0NT1elYp_qLq_e2z-IgL71-Faq7uSNw3YbsCaKW7C5WF7On8L8r1xnwcvSUaw6ym-KiqCWjtpvM1JaQlqmyRbVOXE3UoxZNY46BoyKYh2IqIqp2e1F9mcZIUmn45_fD-cmeL5nHSRFW7D-ELIfQd6RVmYe0BsjOaezpIkVpYpnijDbMw0V4FNeJZLD14gKdPTJkxHWps3tL5y3RE-dYRPG8J7wDuSp3kbD92l5Tj5d8Ng2fC_x9ro1jRtecQ8PUe0B0-Wxbi73ZFNVphy4epI1Kd4QrkHdxsILMeM0HSlqCF7IFbAsazgIoevlhSTozqCOJMuQ5W8__dpPYYrg_3hbrq7Pdp5AFfxe3jjJLcBvWq2MA9RHavUo3YPEPh80dvuJ68TSlQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFSKVHFBvBsoYCQQBxQ1iR3bQUIIUVYtpVUlWGlvIX7RrdikbLJC_TEOXPkxxnlsWZCASy85xM-M55kZzwA8FsxQg3wvpEoXIWOJCFXB4lAqRzNDudLWG4oHh3x3zN5O0skafB_uwviwyoEntozaVNr_I9_2iITWDBVi2_VhEUc7o5enX0JfQcp7WodyGh2K7Nuzr2i-1S_2dvCsnyTJ6M2H17thX2EgVChGmzA2WYybNIkVItXSUE1tErnEWked9xM7JYWRKORdGlORKMudKLjUUaIR8RnFeS_BZUGxFWlJTMS5FJCxHKr1sYyLPrYspm2BmfmxXczMtEYkjVN8eLmN0k3NTlbl4x9K7--xm78Iw9E1uNprseRVh3bXYc2WN2DjoPfT3wR9NB7x6DkpCE49w1dlQ1B_J13cOakcQb2TFIummvr7KZbMu1BdS6YlMV5YNNXsrI0nq0lRGvL-5Me3T3NbPq3JkGPhFowvBNi3Yb2sSrsJxKVo-Jkiy1LlmOKZssylzHAVuYwXWgbwDEGZn3YJO_LW0KHt5esB8LkHfN4BPgA-gDzXfWZ0X6Dj878HRsuB_73W1nCmec8t6vwctwN4tGxGOvfOm6K01cL3kahZ8YzyAO50KLBcM0EjlqKuHIBYQY5lB59DfLWlnB63ucSZ9LWq5N2_b-shbCCx5e_2DvfvwRX8HN5Fy23BejNf2PuolzXqQUsABD5eNMX9BEp6TSQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PUF60%3A+a+prominent+new+target+of+the+autoimmune+response+in+dermatomyositis+and+Sj%C3%B6gren%E2%80%99s+syndrome&rft.jtitle=Annals+of+the+rheumatic+diseases&rft.au=Fiorentino%2C+David+F.&rft.au=Presby%2C+Matthew&rft.au=Baer%2C+Alan+N.&rft.au=Petri%2C+Michelle&rft.date=2016-06-01&rft.issn=0003-4967&rft.eissn=1468-2060&rft.volume=75&rft.issue=6&rft.spage=1145&rft.epage=1151&rft_id=info:doi/10.1136%2Fannrheumdis-2015-207509&rft_id=info%3Apmid%2F26253095&rft.externalDocID=PMC4828328 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-4967&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-4967&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-4967&client=summon |